In 2020, Dr. Manan Shah '03 teamed up with his cousin, Aakash, a software engineer, to develop a platform that delivers home treatments to patients to allow them to build immunity to common allergies. The health-tech company, Wyndly, has grown steadily and just received a venture capital infusion of $2 million to further strengthen and expand its services. Wyndly pledges a fully at-home approach that begins with a home test kit, transitions to in-person or virtual doctor visits that produce a customized treatment plan, and culminates in a shipment of medication directly to patients' homes. Improvements kick in after three months, with complete immunity reached in roughly three years.

Read the full story here.